Assembly Biosciences
Clinical trials sponsored by Assembly Biosciences, explained in plain language.
-
New herpes drug ABI-5366 enters early human safety trials
Disease control CompletedThis early-stage study tested a new drug called ABI-5366 in 115 people to see if it is safe and how the body handles it. Healthy volunteers received a single dose, while people with recurrent genital herpes (caused by HSV-2) received multiple doses. The goal was to measure drug l…
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New herpes drug enters early human testing
Symptom relief CompletedThis early-stage study tested a new drug called ABI-1179 in 103 people. First, healthy volunteers received a single dose to check safety. Then, people with recurrent genital herpes (caused by HSV-2) received multiple doses. The goal was to see if the drug is safe and how the body…
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC
-
New hepatitis d drug candidate takes first safety step in healthy people
Knowledge-focused CompletedThis early-stage study tested the safety and how the body processes a new drug called ABI-6250 in 40 healthy adults. Participants received either the drug or a placebo, and researchers measured side effects and drug levels in the blood. The goal was not to treat disease but to ga…
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC